Related references
Note: Only part of the references are listed.High-risk screening for Fabry disease in a Canadian cohort of chronic kidney disease patients
Christiane Auray-Blais et al.
CLINICA CHIMICA ACTA (2020)
Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study-the FoRWARD study
Sadia Jahan et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia
Andrew Mallett et al.
BMC NEPHROLOGY (2020)
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
Andrew S. Levey et al.
KIDNEY INTERNATIONAL (2020)
Fabry Disease Prevalence in Renal Replacement Therapy in Turkey
Serkan Feyyaz Yalin et al.
NEPHRON (2019)
The Prevalence and Clinical Features of Fabry Disease in Hemodialysis Patients: Russian Nationwide Fabry Dialysis Screening Program
Sergey Moiseev et al.
NEPHRON (2019)
Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study
Maarten Arends et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Fabry Disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac and stroke clinics, 1995-2017
Dana Doheny et al.
JOURNAL OF MEDICAL GENETICS (2018)
Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study
Yavuz Yenicerioglu et al.
RENAL FAILURE (2017)
Newborn screening for Fabry disease in the north-west of Spain
Cristobal Colon et al.
EUROPEAN JOURNAL OF PEDIATRICS (2017)
A simple method for quantification of plasma globotriaosylsphingosine: Utility for Fabry disease
Andrew Talbot et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system
Juana Ines Navarrete-Martinez et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics
Valentina Favalli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study
Kultigin Turkmen et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2016)
Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening
Cassiano Augusto Braga Silva et al.
NEPHRON (2016)
Quality of life in patients with Fabry disease: a systematic review of the literature
Maarten Arends et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance
L. van der Tol et al.
JOURNAL OF MEDICAL GENETICS (2014)
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation
David G. Warnock et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Screening for Fabry disease in high-risk populations: a systematic review
G. E. Linthorst et al.
JOURNAL OF MEDICAL GENETICS (2010)
End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry
Alberto Ortiz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Fabry disease
Dominique P. Germain
ORPHANET JOURNAL OF RARE DISEASES (2010)
X-linked inheritance and its implication in the diagnosis and management of female patients in Fabry disease
D. P. Germain et al.
REVUE DE MEDECINE INTERNE (2010)
Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry
Stephen Waldek et al.
GENETICS IN MEDICINE (2009)
Newborn Screening for Fabry Disease in Taiwan Reveals a High Incidence of the Later-Onset GLA Mutation c.936+919G > A (IVS4+919G > A)
Wuh-Liang Hwu et al.
HUMAN MUTATION (2009)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
William R. Wilcox et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy
Alberto Ortiz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
High incidence of later-onset Fabry disease revealed by newborn screening
Marco Spada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease
Natalie Jansen Street et al.
GENETICS IN MEDICINE (2006)
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females
KD MacDermot et al.
JOURNAL OF MEDICAL GENETICS (2001)
Enzyme replacement therapy in Fabry disease - A randomized controlled trial
R Schiffmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
